BETHESDA, Md., April 1, 2015 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) -- an intellectual property development company committed to the fostering and monetization of intellectual property, today announced that Chardan Capital Markets LLC, a privately held full service global investment bank specializing in micro, small, and mid-cap companies, recently issued an industry note featuring Spherix.

Spherix Logo

The report, authored by James McIlree, CFA, a Senior Analyst at Chardan, was published on March 31, 2015. The report discusses the history of the IP portfolio acquired by Spherix, the company's monetization strategy, and provides comparative statistics related to other companies in the IP monetization sector.

Interested parties can contact Mr. McIlree at Chardan at jmcilree@chardancm.com to obtain a copy of the report.

All reports on Spherix prepared by analysts represent the views of such analysts and are not necessarily those of Spherix.  Spherix is not responsible for the content, accuracy or timelines provided by analysts.

About Spherix

Spherix Incorporated was launched in 1967 as a scientific research company. Spherix is committed to advancing innovation by active participation in the patent market. Spherix draws on portfolios of pioneering technology patents to partner with and support product innovation.

About Chardan Capital Markets, LLC

Chardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles, Sydney and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc. To learn more about Chardan Capital Markets, visit www.chardancm.com.

Forward-Looking Statements

Certain statements in this press release constitute "forward-looking statements" within the meaning of the federal securities laws. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation those set forth in the Company's filings with the Securities and Exchange Commission (the "SEC"), not limited to Risk Factors relating to its patent business contained therein. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law.

Contact:

Investor Relations:

Hayden IR


Brett Mass, Managing Partner


Phone: (646) 536-7331


Email: brett@haydenir.com


www.haydenir.com



Spherix:

Phone: (703) 992-9325


Email: info@spherix.com


www.spherix.com

Logo - http://photos.prnewswire.com/prnh/20131104/PH08853LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/chardan-capital-issues-industry-note-covering-spherix-300058982.html

SOURCE Spherix Incorporated

Copyright 2015 PR Newswire

Alkido Pharma (NASDAQ:AIKI)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Alkido Pharma Charts.
Alkido Pharma (NASDAQ:AIKI)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Alkido Pharma Charts.